Novelix Pharmaceuticals Share Price
Know More₹59.78 2.11 (3.66%)
26-Dec-2025BSE : 536565
Sector : Health care
ISIN Code : INE314I01036
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 26-Dec-2025
| Market Cap (₹ Cr) | 103 |
Traded Value (₹ Cr) | 0.10 |
Volume (Shares) | 15,899 |
Face Value (₹) | 10 |
52-Week High (₹) | 70.16 |
52-Week High Date | 19-Nov-2025 |
52-Week Low (₹) | 24.15 |
52-Week Low Date | 30-Dec-2024 |
All Time High (₹) | 74.60 |
All Time High Date | 12-Jan-2010 |
All Time Low (₹) | 1.85 |
All Time Low Date | 03-Mar-2020 |
Novelix Pharmaceuticals Ltd
Market News
Novelix Pharma. Announcement
Novelix Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 103 |
| EPS - TTM (₹) [C] | 0.00 |
| P/E Ratio (X) [C] | - |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 3.00 |
| Latest Dividend Date | 16-Aug-2012 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 12.51 |
| P/B Ratio (₹) [C] | 4.78 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Data Not Found | |||
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 56.00 60.55 |
| Week Low/High (₹) | 56.00 64.00 |
| Month Low/High (₹) | 49.26 69.00 |
| Year Low/High (₹) | 24.15 70.00 |
| All time Low/High (₹) | 1.85 75.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -3.52% | - | 0.13% | 0.29% |
| 1 Month | 9.81% | - | -0.66% | -0.62% |
| 3 Month | 45.80% | - | 5.74% | 5.63% |
| 6 Month | 76.19% | - | 1.53% | 1.93% |
| 1 Year | - | - | 8.37% | 9.65% |
| 3 Year | 504.45% | - | 40.41% | 44.56% |
Company Info
Company Information
E D & Wholetime Director : VENKATESHWARLU PULLURU
Independent Non Exe. Director : JANARDHAN DAS KABRA
Non-Exec & Non-Independent Dir : Jivamohan Divakar Valluri
Independent Non Exe. Director : Monam Kapoor
Independent Non Exe. Director : Lakshman Samala
Non-Exec & Non-Independent Dir : GNANA PRAKASH GATTU
Independent Non Exe. Director : Mayuri Baidya
Company Sec. & Compli. Officer : Nishita Kalantri
Registered Office: 4-4-231/1/2/ABC Inderbagh, Sultan Bazar,Hyderabad,Telangana-500095 Ph: 91-40-24757370
Email:info@trimurthidrugs.com
FAQs about Novelix Pharmaceuticals Ltd
1. What's the Novelix Pharmaceuticals Ltd share price today?
Novelix Pharmaceuticals Ltd share price was Rs 59.78 at close on 26th Dec 2025. Novelix Pharmaceuticals Ltd share price was up by 3.66% over the previous closing price of Rs 57.67. Novelix Pharmaceuticals Ltd share price trend:
- Last 1 Month: Novelix Pharmaceuticals Ltd share price moved up by 9.81% on BSE.
- Last 3 Months: Novelix Pharmaceuticals Ltd share price moved up by 45.80% on BSE.
- Last 3 Years: Novelix Pharmaceuticals Ltd share price moved up by 504.45% on BSE.
2. How can I quickly analyse the performance of the Novelix Pharmaceuticals Ltd stock?
The performance of the Novelix Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- Price to book value ratio is 4.78
3. What is the market cap of Novelix Pharmaceuticals Ltd?
Novelix Pharmaceuticals Ltd has a market capitalisation of Rs 103 crore.
4. What is Novelix Pharmaceuticals Ltd's 52-week high/low share price?
The Novelix Pharmaceuticals Ltd’s 52-week high share price is Rs 70.16 and 52-week low share price is Rs 24.15.
5. Is the Novelix Pharmaceuticals Ltd profitable?
On a consolidated basis, Novelix Pharmaceuticals Ltd reported a loss of Rs -0.15 crore on a total income of Rs 1.30 crore for the quarter ended 2022.
6. Which are Novelix Pharmaceuticals Ltd’s peers in the Health care sector?
Novelix Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Bal Pharma, Aptus Pharma, Denis Chem Lab, Novelix Pharma., Astal Lab, Bharat Immunolog, Source Natural.
7. Who owns how much in Novelix Pharmaceuticals Ltd?
Key changes to the Novelix Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Novelix Pharmaceuticals Ltd has gone up to 54.82 per cent as of Nov 2025 from 52.75 per cent as of Jun 2025.
